Compare TWST & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TWST | VIRT |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.8B |
| IPO Year | 2018 | 2014 |
| Metric | TWST | VIRT |
|---|---|---|
| Price | $89.09 | $56.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $46.88 | $45.60 |
| AVG Volume (30 Days) | ★ 1.9M | 1.3M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.89% |
| EPS Growth | 63.89 | ★ 72.73 |
| EPS | N/A | ★ 1.99 |
| Revenue | $376,572,000.00 | ★ $3,632,118,000.00 |
| Revenue This Year | $18.91 | N/A |
| Revenue Next Year | $15.07 | $1.34 |
| P/E Ratio | ★ N/A | $28.47 |
| Revenue Growth | 20.32 | ★ 26.25 |
| 52 Week Low | $23.30 | $31.55 |
| 52 Week High | $105.47 | $68.02 |
| Indicator | TWST | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 42.71 |
| Support Level | $87.57 | $32.73 |
| Resistance Level | $105.47 | $64.88 |
| Average True Range (ATR) | 6.38 | 2.48 |
| MACD | -1.70 | -1.17 |
| Stochastic Oscillator | 20.10 | 9.00 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.